BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36058855)

  • 21. A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia.
    Niewerth D; Creutzig U; Bierings MB; Kaspers GJ
    Blood; 2010 Sep; 116(13):2205-14. PubMed ID: 20538803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.
    Qin YZ; Xu LP; Chen H; Jiang Q; Wang Y; Jiang H; Zhang XH; Han W; Chen YH; Wang FR; Wang JZ; Zhu HH; Liu YR; Jiang B; Liu KY; Huang XJ
    Leuk Lymphoma; 2015; 56(11):3116-23. PubMed ID: 25804769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of 18-fluorodeoxyglucose positron emission tomography in children with relapsed/refractory leukemia.
    Kaya Z; Akdemir OU; Atay OL; Akyürek N; Pınarlı FG; Yenicesu İ; Koçak Ü
    Pediatr Hematol Oncol; 2018; 35(7-8):393-406. PubMed ID: 30657003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.
    Pawson R; Potter MN; Theocharous P; Lawler M; Garg M; Yin JA; Rezvani K; Craddock C; Rassam S; Prentice HG
    Br J Haematol; 2001 Dec; 115(3):622-9. PubMed ID: 11736947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival.
    Dai N; Liu H; Deng S; Sang S; Wu Y
    Technol Cancer Res Treat; 2021; 20():15330338211056478. PubMed ID: 34806464
    [No Abstract]   [Full Text] [Related]  

  • 26. Unusual maxillary osteoblastic and osteolytic lesions presenting as an initial manifestation of childhood acute myeloid leukemia: A case report.
    Shimizu R; Ohga N; Miyakoshi M; Asaka T; Sato J; Kitagawa Y
    Quintessence Int; 2017; 48(2):149-153. PubMed ID: 27981267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
    Fujieda A; Nishii K; Tamaru T; Otsuki S; Kobayashi K; Monma F; Ohishi K; Nakase K; Katayama N; Shiku H
    Leuk Res; 2006 Aug; 30(8):1053-7. PubMed ID: 16504290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.
    Suciu S; Mandelli F; de Witte T; Zittoun R; Gallo E; Labar B; De Rosa G; Belhabri A; Giustolisi R; Delarue R; Liso V; Mirto S; Leone G; Bourhis JH; Fioritoni G; Jehn U; Amadori S; Fazi P; Hagemeijer A; Willemze R;
    Blood; 2003 Aug; 102(4):1232-40. PubMed ID: 12714526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary peritoneal myeloid sarcoma in association with
    Kuhlman JJ; Abdel Rahman ZH; Jiang L; Menke DM; Foran JM; Murthy HS
    Leuk Res Rep; 2021; 15():100238. PubMed ID: 33816105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18 F-FDG PET/CT Imaging of Isolated Myeloid Sarcoma in the Right Humerus.
    Xie H; Zhang H; Xiao L; Li L
    Clin Nucl Med; 2024 Feb; 49(2):201-203. PubMed ID: 38170922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approaches in allogenic transplantation in AML.
    Pei X; Huang X
    Semin Hematol; 2019 Apr; 56(2):147-154. PubMed ID: 30926091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].
    Imanaka R; Katayama Y; Iwato K; Kyo K; Okatani T; Itagaki M; Katsutani S; Asaoku H
    Rinsho Ketsueki; 2018; 59(1):58-63. PubMed ID: 29415939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Yeshurun M; Labopin M; Blaise D; Cornelissen JJ; Sengeloev H; Vindelov L; Kuball J; Chevallier P; Craddock C; Socie G; Bilger K; Schouten HC; Fegueux N; Goker H; Maertens J; Bunjes D; Arnold R; Nagler A; Mohty M
    Cancer; 2014 Mar; 120(6):855-63. PubMed ID: 24338939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
    Niu N; Cui R; Li F
    Clin Nucl Med; 2016 Mar; 41(3):235-6. PubMed ID: 26505855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of decitabine in pericardial myeloid sarcoma.
    Evers D; Bär BMAM; Gotthardt M; van der Velden WJFM
    Int J Hematol; 2018 Aug; 108(2):121-122. PubMed ID: 29779081
    [No Abstract]   [Full Text] [Related]  

  • 38. Multiple extramedullary relapses without bone marrow involvement after second allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Yoo SW; Chung EJ; Kim SY; Ko JH; Baek HS; Lee HJ; Oh SH; Jeon SC; Lee WS; Park CK; Lee CH
    Pediatr Transplant; 2012 Jun; 16(4):E125-9. PubMed ID: 21923886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation.
    Wang YF; Li Q; Xu WG; Xiao JY; Pang QS; Yang Q; Zhang YZ
    Cancer Biol Med; 2013 Dec; 10(4):232-5. PubMed ID: 24349834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.